Pharmaron Beijing Co., Ltd. (HKG:3759)

Pharmaron Beijing Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,205	1,690	5,919	1,497	3,544	2,942
Short-Term Investments	-	257.27	179.36	613.24	1,080	-
Trading Asset Securities	1,075	1,120	621.98	745.36	1,555	910.01
Cash & Short-Term Investments	2,280	3,068	6,720	2,856	6,178	3,852
Cash Growth	-12.25%	-54.35%	135.30%	-53.77%	60.37%	-17.03%
Accounts Receivable	2,949	2,871	2,636	2,214	1,424	1,210
Other Receivables	120.53	126.89	80.98	71.16	92.43	33.38
Receivables	3,069	2,998	2,717	2,286	1,516	1,249
Inventory	1,396	1,117	1,013	1,041	680.04	281.62
Other Current Assets	1,068	425.67	423.68	352.82	269.05	157.76
Total Current Assets	7,813	7,608	10,874	6,536	8,644	5,540
Property, Plant & Equipment	11,574	10,798	10,062	8,464	5,811	3,799
Long-Term Investments	1,211	883.04	1,005	1,008	762.67	401.7
Goodwill	2,980	2,761	2,781	2,688	2,096	1,166
Other Intangible Assets	858.65	791	789.06	802.53	692.94	566.08
Long-Term Deferred Tax Assets	250.18	192.68	153.22	58.79	15.6	8.44
Long-Term Deferred Charges	620.04	678.5	520.47	496.38	171.6	234.27
Other Long-Term Assets	493.69	191.98	267.09	438.91	195.99	193.05
Total Assets	25,801	23,927	26,477	20,493	18,389	11,909
Accounts Payable	564.64	477.09	412.22	406.35	315.53	191.5
Accrued Expenses	808.32	853.93	805.65	784.92	626.21	472.44
Short-Term Debt	1,239	764.97	577.07	662.77	421.76	377.27
Current Portion of Long-Term Debt	471.8	282.34	150.34	74.94	60.54	8.88
Current Portion of Leases	-	149.51	185.32	164.03	95.29	83.92
Current Income Taxes Payable	218.62	160.08	184.55	145.87	81.34	27.62
Current Unearned Revenue	1,119	834.86	740.87	832.14	679.62	473.29
Other Current Liabilities	772.49	701.23	598.47	841.4	701.7	346.87
Total Current Liabilities	5,194	4,224	3,654	3,912	2,982	1,982
Long-Term Debt	4,296	4,377	8,200	4,454	4,423	394.81
Long-Term Leases	381.28	401.31	585.2	760.51	284.34	186.61
Long-Term Unearned Revenue	433.09	409.98	391.71	152.38	149.44	158.13
Long-Term Deferred Tax Liabilities	314.56	291.87	290.04	261.01	173.3	106.91
Other Long-Term Liabilities	-	-	117.58	112.09	81.56	146.81
Total Liabilities	10,619	9,705	13,239	9,653	8,094	2,975
Common Stock	1,778	1,778	1,787	1,191	794.18	794.39
Additional Paid-In Capital	4,931	5,008	5,222	5,254	6,008	6,028
Retained Earnings	8,045	7,257	5,818	4,574	3,554	2,131
Treasury Stock	-304.89	-416.27	-463.45	-668.04	-301.83	-45.47
Comprehensive Income & Other	163.24	-7.76	193.72	197.26	74.15	-38.22
Total Common Equity	14,613	13,619	12,557	10,549	10,129	8,870
Minority Interest	569.14	603.54	681.25	291.25	166.07	63.42
Shareholders' Equity	15,182	14,223	13,238	10,840	10,295	8,934
Total Liabilities & Equity	25,801	23,927	26,477	20,493	18,389	11,909
Total Debt	6,389	5,975	9,698	6,117	5,285	1,051
Net Cash (Debt)	-4,109	-2,908	-2,977	-3,260	893.04	2,801
Net Cash Growth	-	-	-	-	-68.12%	-22.27%
Net Cash Per Share	-2.33	-1.64	-1.68	-1.84	0.49	1.57
Filing Date Shares Outstanding	1,763	1,766	1,787	1,787	1,787	1,787
Total Common Shares Outstanding	1,763	1,766	1,787	1,787	1,787	1,787
Working Capital	2,619	3,384	7,220	2,624	5,662	3,559
Book Value Per Share	8.29	7.71	7.03	5.90	5.67	4.96
Tangible Book Value	10,774	10,068	8,987	7,058	7,340	7,138
Tangible Book Value Per Share	6.11	5.70	5.03	3.95	4.11	3.99
Buildings	-	4,921	3,971	3,347	2,473	1,673
Machinery	-	6,274	5,149	4,265	2,919	2,194
Construction In Progress	-	2,254	2,633	1,671	1,374	820.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.